Claire Pellorce-Piquet
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Interleukin-18 Binding Protein (IL-18BP) Deficiency Affects Lymphocyte Activation and IL-18 Expression in a Mouse Model of Liver Inflammation.
Journal: European journal of immunology
Published: October 23, 2024
Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation.
Journal: International journal of cancer
Published: July 12, 2023
RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl4-Induced Liver Injury.
Journal: International journal of molecular sciences
Published: May 06, 2022
Questioning the RIPK1 kinase activity involvement in acetaminophen-induced hepatotoxicity in mouse.
Journal: Free radical biology & medicine
Published: September 02, 2021
Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: April 08, 2021
Intrahepatocytic necroptosis is dispensable for hepatocyte death in murine immune-mediated hepatitis.
Journal: Journal of hepatology
Published: April 22, 2020
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Journal: Biochemical pharmacology
Published: April 20, 2020
Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response.
Journal: Cancers
Published: April 14, 2020
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis.
Journal: Cell death & disease
Published: July 31, 2018
Last Updated: 09/26/2026